Cited by 116Bipolar Disorder and TreatmentTreatment of Major DepressionPersonality Disorders and Psychopathology

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Antidepressants in bipolar depression: an enduring controversy

Open access

Gitlin, Michael J.·2018·International Journal of Bipolar Disorders

DOI 10.1186/s40345-018-0133-9PMC PMC6269438

Open this paper in CoChat — free account Open PDF

Abstract

The proper place and the optimal use of antidepressants in treating bipolar depression continues to be an area of great interest and greater controversy with passionate opinions more common than good studies. Even the handful of meta-analyses in the area disagree with each other. Overall, the evidence that antidepressants are effective in treating bipolar depression is weak. Additionally, many experts and clinicians worry greatly about the capacity of antidepressants to cause affective switching or mood destabilization. Yet, in short term controlled studies, with most patients also taking mood stabilizers, antidepressants are not associated with switches into mania/hypomania. Evidence of cycle acceleration with antidepressants primarily reflects treatment with older antidepressants, e.g., tricyclics. Similar evidence with modern antidepressants such as selective serotonin reuptake inhibitors (SSRIs) is lacking. The key questions should not be: are antidepressants effective in bipolar depression?; And: do antidepressants worsen the course of bipolar disorder? Rather, the question should be focused on subgroups: for which patients are antidepressants helpful and safe, and for which patients will they be harmful? Predictors of affective switching with antidepressants include: bipolar I disorder (vs. bipolar II), mixed features during depression, tricyclics vs. modern antidepressants, rapid cycling and possibly a history of drug abuse, especially stimulant abuse. Additionally, a number of recent studies have demonstrated both the safety and efficacy of antidepressant monotherapy in treating bipolar II depression. Finally, a subgroup of bipolar individuals need antidepressants in addition to mood stabilizers as part of an optimal maintenance treatment regimen.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s40345-018-0133-9

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

MANIC DEPRESSIVE ILLNESS
Davenport, Y. B., Adland, M. L., Gold, P. W., & Goodwin, F. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQUEEN, G. M., McIntyre, R. S., Sharma, V., et al. (2012) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,230
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770
Antidepressant-induced mania and cycle acceleration: a controversy revisited
Altshuler, L. L., Post, R. M., Leverich, G. S., Mikalauskas, K., ROSOFF, A. S., & Ackerman, L. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1130 · Cited by 607
Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials
Gijsman, H. J., Geddes, J. R., Rendell, J. M., Nolen, W. A., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1537 · Cited by 567
Manic depressive illness
Goodwin, F. K., & Jamison, K. R. (2007) · Cited by 534
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
Tohen, M. F., Frank, E., Bowden, C. L., Colom, F., Ghaemi, S. N., Yatham, L. N., Malhi, G. S., Calabrese, J. R., Nolen, W. A., Vieta, E., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00726.x · Cited by 527

Show all 63 references

Sorted by citations

Diagnosis and Treatment of Bipolar Disorder
Nierenberg, A. A., Agustini, B., Köhler‐Forsberg, O., Cusin, C., Katz, D., Sylvia, L. G., Peters, A. T., & Berk, M. (2023) · JAMA · doi:10.1001/jama.2023.18588 · Cited by 448
Bipolar depression: a major unsolved challenge
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0160-1 · Cited by 235
Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps
Kuehner, C., & Nayman, S. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01286-0 · Cited by 93
Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers
Dionisie, V., Filip, G. A., Manea, M. C., Movileanu, R. C., Moisa, E., Manea, M., Riga, S., & Ciobanu, A. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091924 · Cited by 82
Patterns of pharmacotherapy for bipolar disorder: A GBC survey
Singh, B., Yocum, A. K., Strawbridge, R., Burdick, K. E., Millett, C. E., Peters, A. T., Sperry, S. H., Fico, G., Vieta, E., Verdolini, N., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13366 · Cited by 82
A mechanistic account of serotonin’s impact on mood
Michely, J., Eldar, E., Martin, I. M., & Dolan, R. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16090-2 · Cited by 72
Clinical decision support for bipolar depression using large language models
Perlis, R. H., Goldberg, J. F., Ostacher, M. J., & Schneck, C. D. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01841-2 · Cited by 75
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
Pires, P. C., Paiva‐Santos, A. C., & Veiga, F. (2023) · Pharmaceuticals · doi:10.3390/ph16101424 · Cited by 61
Bipolar depression: a review of treatment options
Levenberg, K., & Cordner, Z. A. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100760 · Cited by 59
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders
Walkerly, A., Leader, L. D., Cooke, E., & VandenBerg, A. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s240856 · Cited by 50
Brain stimulation treatment for bipolar disorder
Mutz, J. (2022) · Bipolar Disorders · doi:10.1111/bdi.13283 · Cited by 50
Drug repositioning for psychiatric and neurological disorders through a network medicine approach
Dias, T. L., Schuch, V., Beltrão-Braga, P. C. B., Martins‐de‐Souza, D., Brentani, H., Franco, G. R., & Nakaya, H. I. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0827-5 · Cited by 44
The existential crisis of bipolar II disorder
Gitlin, M. J., & Malhi, G. S. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0175-7 · Cited by 42
Self-citation
Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
Bartoli, F., Cavaleri, D., Bachi, B., Moretti, F., Riboldi, I., Crocamo, C., & Carrà, G. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.018 · Cited by 41
Drug treatment for patients with bipolar disorders in psychiatric practices in Germany in 2009 and 2018
Bohlken, J., Bauer, M., & Kostev, K. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112965 · Cited by 35
A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs
Barbuti, M., Menculini, G., Verdolini, N., Pacchiarotti, I., Kotzalidis, G. D., Tortorella, A. A. V., Vieta, E., & Perugi, G. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.04.013 · Cited by 34
Trends in prescriptions of lithium and other medications for patients with bipolar disorder in office-based practices in the United States: 1996–2015
Lin, Y., Mojtabai, R., Goes, F. S., & Zandi, P. P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.063 · Cited by 34
Repetitive transcranial magnetic stimulation in the treatment of bipolar disorder
Hett, D., & Marwaha, S. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320973790 · Cited by 32
Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis
Tundo, A., Betrò, S., de Filippis, R., Marchetti, F., Nacca, D., Necci, R., & Iommi, M. (2023) · Life · doi:10.3390/life13041043 · Cited by 31
Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis
McGowan, N. M., Kim, D. S., Crespo, M. D. A., Bisdounis, L., Kyle, S. D., & Saunders, K. (2022) · CNS Drugs · doi:10.1007/s40263-022-00911-7 · Cited by 33
“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use
DellaCrosse, M., Pleet, M., Morton, E., Ashtari, A., Sakai, K., Woolley, J., & Michalak, E. (2022) · PLOS ONE · doi:10.1371/journal.pone.0279073 · Cited by 28
Ketamine for bipolar depression: an updated systematic review
Fancy, F., Haikazian, S., Johnson, D. E., Chen-Li, D. C. J., Levinta, A., Husain, M. I., Mansur, R. B., & Rosenblat, J. D. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231202723 · Cited by 29
Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression
Montano, C. B., Jackson, W., Vanacore, D., & Weisler, R. H. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2023.2189868 · Cited by 26
An update on potential pharmacotherapies for cognitive impairment in bipolar disorder
Johnson, D. E., McIntyre, R. S., Mansur, R. B., & Rosenblat, J. D. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2194488 · Cited by 24
Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges
Sepede, G., Brunetti, M., & Giannantonio, M. D. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s202881 · Cited by 21
Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis
Jain, R., Kong, A. M., Gillard, P. J., & Harrington, A. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02112-6 · Cited by 23
Evaluating the efficacy and safety of antidepressants in patients with bipolar disorder
Cheniaux, E., & Nardi, A. E. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1651291 · Cited by 22
Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptoms
Pilhatsch, M., Stamm, T. J., Stahl, P., Lewitzka, U., Berghöfer, A., Sauer, C., Gitlin, M. J., Frye, M. A., Whybrow, P. C., & Bauer, M. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0155-y · Cited by 20
Self-citation
Depression and anxiety management in cirrhosis
Zimbrean, P. C., & Jakab, S. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000600 · Cited by 18
Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: A narrative review
Ghafori, S. S., Yousefi, Z., Bakhtiari, E., hasani, M. H. M. M., & Hassanzadeh, G. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100734 · Cited by 26
Diagnostic conversion from unipolar to bipolar affective disorder–A population-based study
Jo, Y. T., Joo, S. W., Kim, H., Ahn, S., Choi, Y. J., Choi, W., Park, S. Y., & Lee, J. S. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.01.082 · Cited by 17
Quetiapine in the Anxiety Dimension of Mood Disorders
Crapanzano, C., Damiani, S., & Guiot, C. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001420 · Cited by 15
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis
Park, J. H., Núñez, N. A., Gardea‐Resendez, M., Gerberi, D., Breitinger, S. A., Veldić, M., Frye, M. A., & Singh, B. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4433 · Cited by 16
Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review
Kamal, Z. M., Dutta, S., Rahman, S., Etando, A., Hasan, E., Nahar, S. N., Fakuradzi, W. F. S. W. A., Sinha, S., Haque, M., & Ahmad, R. (2022) · Cureus · doi:10.7759/cureus.29332 · Cited by 16
Correlates of current rapid-cycling bipolar disorder: Results from the Italian multicentric RENDiBi study
Buoli, M., Cesana, B. M., Maina, G., Conca, A., Fagiolini, A. M., Steardo, L., Altamura, A. C., Dell’Osso, B. M., & on behalf of the ISBD Italian Chapter Epidemiologic Group (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.09.001 · Cited by 14
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality
Olgiati, P., & Serretti, A. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000479 · Cited by 12
Status of Type II vs. Type I Bipolar Disorder: Systematic Review with Meta-Analyses
Hernandorena, C. V., Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2023) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000371 · Cited by 12
Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder
Bui, T. A., O’Croinin, B. R., Dennett, L., Winship, I. R., & Greenshaw, A. J. (2025) · Microbiology · doi:10.1099/mic.0.001568 · Cited by 14
Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder
Tokumitsu, K., Yasui‐Furukori, N., Adachi, N., Kubota, Y., Watanabe, Y., Miki, K., Azekawa, T., Edagawa, K., Katsumoto, E., Hongo, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0262129 · Cited by 13
Combining predominant polarity and affective spectrum concepts in bipolar disorder: towards a novel theoretical and clinical perspective
Bartoli, F., Malhi, G. S., & Carrà, G. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00336-9 · Cited by 14
A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder
Brown, E. S., McArdle, M., Palka, J. M., Bice, C., Ivleva, E. I., Nakamura, A., McNutt, M., Patel, Z., Holmes, T., & Tipton, S. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.12.006 · Cited by 12
Advancements in Valproate Therapy for Seizures, Migraines, and Bipolar Disorders
Bairy, L. K., & Madhyastha, S. (2025) · Medical Principles and Practice · doi:10.1159/000543555 · Cited by 11
Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action
Repple, J., Bayas, M., Möser, C., Kobayashi, N. F., & Reif, A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.903 · Cited by 10
Global Trends in the Use of Pharmacotherapy for the Treatment of Bipolar Disorder
Yocum, A. K., & Singh, B. (2025) · Current Psychiatry Reports · doi:10.1007/s11920-025-01606-8 · Cited by 15
Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram
Bohlken, J., Riedel-Heller, S. G., Bauer, M., & Kostev, K. (2021) · Pharmacopsychiatry · doi:10.1055/a-1348-1523 · Cited by 10
Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study
Cuomo, A., Pardossi, S., Barillà, G., Carmellini, P., Firenzuoli, B., Tarantino, F., Tinturini, R., & Fagiolini, A. M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.059 · Cited by 10
Prevalence and psychiatric comorbidities of night-eating behavior in obese bariatric patients: preliminary evidence for a connection between night-eating and bipolar spectrum disorders
Brancati, G. E., Barbuti, M., Calderone, A., Fierabracci, P., Salvetti, G., Weiss, F., Santini, F., & Perugi, G. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01306-1 · Cited by 9
Relationship of free thyroxine and triiodothyronine on recurrence in maintenance therapy for bipolar depression
Wang, X. B., Luo, J., Yuan, X., Chen, X., Yu, H., Zhu, X., & Wang, G. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103086 · Cited by 9
Health disparities in the treatment of bipolar disorder
Tchikrizov, V., Ladner, M. E., Caples, F. V., Morris, M., Spillers, H., Jordan, C. D., Balls‐Berry, J. E., Taylor-Desir, M. J., Frye, M. A., & Vallender, E. J. (2023) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2023.100101 · Cited by 8
Incidence of and factors associated with manic episodes and bipolar disorder in the decade following depression onset in Germany
Jacob, L., Bohlken, J., & Kostev, K. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.004 · Cited by 8
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response
Köhler‐Forsberg, O., Sloth, K. H., Sylvia, L. G., Thase, M. E., Calabrese, J. R., Tohen, M. F., Bowden, C. L., McInnis, M. G., Kocsis, J. H., Friedman, E. S., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114194 · Cited by 9
Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD)
Montano, C. B., Jackson, W. C., Vanacore, D., & Weisler, R. H. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s337703 · Cited by 8
Treatment of bipolar depression: clinical practice vs. adherence to guidelines—data from a Bavarian drug surveillance project
Kriner, P., Brieger, P., Pogarell, O. M., Schüle, C., Mußmann, L., Korbmacher, J. M., & Seemüller, F. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1425549 · Cited by 8
Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data
Vieta, E., McIntyre, R. S., Yu, J., Aronin, L. C., Kramer, K., & Nguyen, H. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.119 · Cited by 7
Global perspectives on bipolar disorder treatment: in-depth comparative analysis of international guidelines for medication selection
Park, J. H., Fernando, K., Park, Y. H., & Park, E. O. (2024) · BJPsych Open · doi:10.1192/bjo.2024.27 · Cited by 7
Trends and determinants of prescription of lithium and antidepressants for bipolar disorder in a large health care system between 2017 and 2022
Steger, C., Birckhead, B., Raghunath, S., Straub, J., Sthapit, S., Albert, M. C., Goes, F. S., & Zandi, P. P. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.006 · Cited by 6
Clinical experience with parenteral trazodone in mood disorders: A literature review
Crapanzano, C., Casolaro, I., & Krupa, A. J. (2024) · Psychiatria Polska · doi:10.12740/pp/182933 · Cited by 6
Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder
Fornaro, M., Miola, A., Berardis, D. D., Squassina, A., Manchia, M., & Solmi, M. (2025) · Brain Sciences · doi:10.3390/brainsci15050430 · Cited by 6
Artificial Intelligence and Bipolar Disorder: Applications of Machine Learning Models for Diagnosis, Treatment, and Outcome Prediction
Bartoli, F., Cavaleri, D., & Crocamo, C. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap44494 · Cited by 7
Depression, Angststörungen, bipolare Störung, Schizophrenie, Aufmerksamkeitsdefizithyperaktivitätssyndrom
Seifert, J., Bleich, S., & Seifert, R. (2022) · Springer eBooks · doi:10.1007/978-3-662-66303-5_22 · Cited by 5
Unmet Needs in Psychiatry: Bipolar Depression
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_4 · Cited by 5
Clinical practice guidelines for the management of bipolar disorder: 2025 update
Menon, V., Ganesh, R., Deep, R., Sarkhel, S., Goswami, S., Mohapatra, D., Munoli, R. N., Sharma, P., Reddy, M., & Muralidharan, K. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_1186_25 · Cited by 5
Addressing the unmet needs of bipolar disorder in Australia and beyond
Cotton, S., Hasty, M. K., Mitchell, P. B., Murray, G., Hickie, I. B., McGorry, P. D., Walder, K. R., Dean, O. M., Mihalopoulos, C., Yung, A. R., et al. (2025) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674251361727 · Cited by 5
Right ventrolateral and left dorsolateral 10 Hz transcranial magnetic stimulation as an add-on treatment for bipolar I and II depression: a double-blind, randomised, three‐arm, sham-controlled study
Novák, T., Kostýlková, L., Bareš, M., Renková, V., Hejzlar, M., Renka, J., Baumann, S., Laskov, O., & Klírová, M. (2024) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2024.2357110 · Cited by 4
Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression
Moderie, C., Nuñez, N., Comai, S., Saint-Laurent, M., Fielding, A., Low, N., & Gobbi, G. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001500 · Cited by 4
Addressing depressive disorders among people with HIV.
Fuenmayor, A., & Cournos, F. (2022) · PubMed Central · Cited by 4
Lithium and lamotrigine for the treatment of bipolar II disorder – a systematic review and meta-analysis of randomized trials
Fredskild, M. U., Bruun, C. F., Vinberg, M., Faurholt‐Jepsen, M., Kessing, L. V., & Munkholm, K. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.125 · Cited by 5
Lithium heute — ein Update seiner Wirksamkeit und Risiken
Müller-Oerlinghausen, B. (2019) · NeuroTransmitter · doi:10.1007/s15016-019-6601-3 · Cited by 3
Knowledge Augmentation for Early Depression Detection
Kulkarni, H., MacAvaney, S., Goharian, N., & Frieder, O. (2023) · Studies in computational intelligence · doi:10.1007/978-3-031-36938-4_14 · Cited by 3
Risk of Switch to Mania/Hypomania in Bipolar Depressive Patients Treated with Antidepressants: A Real-World Study
Feng, L., Wang, W., Yin, C., Li, J., Zhang, X., Chang, X., Feng, Z., Zandt, M. V., You, S. C., Seager, S. L., et al. (2025) · Health Data Science · doi:10.34133/hds.0209 · Cited by 2
Depression, Angststörungen, bipolare Störung, Schizophrenie, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung
Seifert, J., Bleich, S., & Seifert, R. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_22 · Cited by 2
Patterns and trends of medication use among patients with bipolar disorder in Northeast China: A study from a large psychiatric center (2013−2022)
Zhang, Y. L., Yao, M., Li, H., Wang, Y., Hao, S., Pan, G., Xu, H., Han, X., Zhou, G., Shao, L., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119920 · Cited by 2
Antidepressant use in older age bipolar disorder (OABD): Results from the GAGE-BD international consortium
Rigas, C., Lavín, P., Chen, P., Torres-Platas, S. G., Su, C., Eyler, L. T., Olagunju, A. T., Teixeira, A. L., Dols, A., Alda, M., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120704 · Cited by 2
Clinical and genetic correlates of a circadian subtype of depression in the Australian Genetics of Depression Study
Tonini, E., Crouse, J. J., Shin, M., Carpenter, J. S., Mitchell, B. L., Byrne, E. M., Lind, P. A., Gordon, S. D., Parker, R., Hockey, S. J., et al. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10798 · Cited by 2
Randomized Controlled Trials and the Efficacy of Psychotropic Medications
Dunlop, B. W., & Ribeiro, C. M. D. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_4 · Cited by 2
Anti‐manic effect of deep brain stimulation of the ventral tegmental area in an animal model of mania induced by methamphetamine
Varela, R. B., Boschen, S. L., Yates, N. J., Houghton, T., Blaha, C. D., Lee, K. H., Bennet, K. E., Kouzani, A. Z., Berk, M., Quevedo, J., et al. (2024) · Bipolar Disorders · doi:10.1111/bdi.13423 · Cited by 2
Prior psychiatric morbidity and differential psychopharmacological treatment patterns: Exploring the heterogeneity of bipolar disorder in a nationwide study of 9594 patients
Ratheesh, A., Speed, M. S., Salagre, E., Berk, M., Rohde, C., & Østergaard, S. D. (2024) · Bipolar Disorders · doi:10.1111/bdi.13432 · Cited by 2
Affective Disorders, Pharmacogenomics, and Psychiatric Illness-Related Cardiometabolic Problems
Kalin, N. H. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240428 · Cited by 2
Valproate Adjuvant Cognitive Behavioral Therapy in Panic Disorder Patients With Comorbid Bipolar Disorder: Case Series and Review of the Literature
Choi, K. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0113 · Cited by 2
Comparison of the efficacy of venlafaxine and bupropion in the treatment of depressive episode in patients with bipolar II disorder
Fakhri, A., Asadi, K., Pakseresht, S., Norouzi, S., & Rostami, H. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1258_22 · Cited by 1
Drug utilization study of mood stabilizers and antipsychotics drugs among bipolar disorder patients
Lolita, L., & Johan, I. M. (2024) · BIO Web of Conferences · doi:10.1051/bioconf/202414801011 · Cited by 1
The use of antidepressants for bipolar disorder - a controversy between science and clinical practice
Kessing, L. V. (2025) · Danish Medical Journal · doi:10.61409/a07250539 · Cited by 1
Comparative effectiveness of selective serotonin reuptake inhibitors versus serotonin-norepinephrine reuptake inhibitors in the risk of diagnostic conversion from unipolar depression to bipolar disorder
Yoo, K. H., Lee, K. J., Lee, S. M., Han, C., Park, R. W., & Jo, Y. T. (2025) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2025.2600083 · Cited by 1
Antidepressant treatment and risk of subsequent bipolar disorder in adolescents with unipolar depression
Talukder, A., Kougianou, I., O’Hare, K., Healy, C., & Kelleher, I. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2025-302146 · Cited by 1
Pilot Trial of Adjunctive Curcumin for Treatment-Resistant Bipolar Depression in Youth: Focus on Inflammation and Oxidative Stress
Osei-Bonsu, G. A., Dimick, M. K., Kennedy, K. G., Barton, J. S., Sultan, A. A., Young, L. T., Andreazza, A. C., & Goldstein, B. I. (2026) · Journal of Child and Adolescent Psychopharmacology · doi:10.1177/10445463251413071 · Cited by 2
Hallucinations during bipolar depressive episode treated with bupropion after alcohol withdrawal surgery: a case report
Kong, X., Cao, L., Han, X., Dong, P., & Chen, X. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1750892 · Cited by 1
SSRI versus SNRI initiation and incident bipolar disorder in tertiary psychiatric care: an active-comparator cohort study from the United Arab Emirates
Bokhari, S. A., Elnour, A. O., & Elnoor, M. (2026) · International Journal of Bipolar Disorders · doi:10.1186/s40345-026-00426-w · Cited by 1
Randomized Controlled Trials and the Efficacy of Psychotropic Medications
Dunlop, B. W., & Ribeiro, C. M. D. F. (2019) · Springer eBooks · doi:10.1007/978-3-319-56015-1_4-1 · Cited by 2
Depression, Angststörungen, bipolare Störung, Schizophrenie, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung
Seifert, J., Bleich, S., & Seifert, R. (2023) · Springer eBooks · doi:10.1007/978-3-662-68371-2_22 · Cited by 1
Analysis of maintenance pharmacotherapy in Chinese bipolar disorder patients: Guideline concordance and adjunctive medication use
Lin, J., Liu, H., Wang, Z., Wu, C., Li, Y., Zhou, J., Xu, G., Pan, M., Chen, Z., Li, W., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.096 · Cited by 1
Managing Bipolar Disease Complicated with Psychosis in Conjunction with Polypharmacy, Parkinson’s Disease, and Multiple Comorbidities
Irizarry, R., Gomez, A. E. S., Miles, S., & Acosta, J. T. (2022) · Case Reports in Psychiatry · doi:10.1155/2022/3813929 · Cited by 1
The nature of depression in bipolar disorder
Perich, T., Mitchell, P. B., & Moustafa, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817676-4.00009-2 · Cited by 1
Data impress…but beliefs seduce
Gitlin, M. J. (2019) · Bipolar Disorders · doi:10.1111/bdi.12777
Self-citation
Another Step Toward Clarifying the Benefits and Burdens of Selective Serotonin Reuptake Inhibitors
Wulsin, L. R. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000735
The case for and against selective serotonin reuptake inhibitors in rapid cycling bipolar disorder
Semenov, D., & Quinn, J. (2021) · University of Western Ontario Medical Journal · doi:10.5206/uwomj.v89i1.8588
Manic Episode Induced by Lamotrigine in Rapid Cycling Bipolar Disorder
Ramos, A. L., Salgado, H., & Bragança, M. (2021) · Cureus · doi:10.7759/cureus.16184
Which patients with bipolar depression receive antidepressant augmentation? Results from an observational multicenter study
Musetti, L., Tundo, A., Cambiali, E., Grande, C. D., de Filippis, R., Franceschini, C., Proietti, L., Betrò, S., Marazziti, D., & Dell’Osso, L. (2021) · CNS Spectrums · doi:10.1017/s109285292100078x
Evidence-Based Principles for Bipolar Disorder Treatment
(2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17303
Anesthesia management for patient with bipolar disorder complicated with hypothyroidism during oral surgery: a case report.
Li, Y., Ji, Y., & Luo, Q. (2023) · PubMed Central · doi:10.7518/hxkq.2023.2022448
The woman whose kidneys could not handle lithium
Gilfert, J. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108623872.025

Authors: Gitlin, M. J.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Gitlin, Michael J.
ORCID: Gitlin, Michael J.
Venue: International Journal of Bipolar Disorders
Publisher: Springer Science and Business Media LLC
Published: 2018-12
Volume: 6
Issue: 1
Pages: 25-25
ISSN: 2194-7511 (ISSN-L)
DOI: 10.1186/s40345-018-0133-9
PMC: PMC6269438
OpenAlex: W2895700889
Cited by: 116
References: 63
Citations by year: 2026: 14 · 2025: 24 · 2024: 15 · 2023: 16 · 2022: 15 · 2021: 13 · 2020: 11 · 2019: 8
FWCI: 1.22
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
Locations: International Journal of Bipolar Disorders (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, other-oa)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: International Society for Bipolar Disorders
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords: antidepressants, bipolar depression, bipolar disorder, tricyclic antidepressants, selective serotonin reuptake inhibitors, bipolar II depression, bipolar I disorder, mixed features, rapid cycling, stimulant abuse, antidepressant monotherapy, mood stabilizers, maintenance therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antidepressants in bipolar depression: an enduring controversy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks